Game-Changing Obesity Drugs Go Mainstream: What Scientists Are Learning
May 24, 2023
(Nature) – A new generation of drugs is revolutionizing the treatment of obesity and astonishing researchers with their potency. The drug semaglutide, for example, enabled one-third of clinical-trial participants to shed at least 20% of their body weight. Tirzepatide, a competing therapy, achieved similar results in more than half of study participants. Despite their high effectiveness, researchers are learning that these drugs are not necessarily the solution for everyone living with obesity. “Everybody wants to try them but not everyone responds to them,” says Andres Acosta, an obesity specialist at Mayo Clinic in Rochester, Minnesota. (Read More)